Antihypertensive Efficacy and Tolerability of Lercanidipine in Daily Clinical Practice. The ELYPSE Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antihypertensive Efficacy and Tolerability of Lercanidipine in Daily Clinical Practice. The ELYPSE Study

Published:2002-01 Issue:2 Volume:11 Page:95-100
ISSN:0803-7051
Container-title:Blood Pressure
language:en
Short-container-title:Blood Pressure

Author:

Barrios Vivencio,Navarro Angel,Esteras Antonio,Luque Manuel,Romero Joaquima,Tamargo Juan,Prieto Luis,Carrasco Jose Luis,Herranz Inmaculada,Navarro-Cid Josefa,Ruilope Luis M.

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/08037050211265

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lercanidipine’s Antioxidative Effect Prevents Noise-Induced Hearing Loss;Antioxidants;2024-03-07

2. New Insights into the Nephroprotective Potential of Lercanidipine;International Journal of Molecular Sciences;2023-09-13

3. Metabolic neutral nephroprotective antihypertensive drugs: Beta blockers and calcium channel blockers;Galenika Medical Journal;2023

4. Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review;CardioSomatics;2022-07-29

5. Comparison Between Lercanidipine and Amlodipine for Efficacy and Tolerability in Patients with Hypertension;Pakistan Journal of Medical and Health Sciences;2021-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP